Apellis Pharmaceuticals VALIANT Top Line Phase III Results Conference Call Aug 8, 2024 8:00 AM EDT Click here for webcast Supporting Materials Apellis Pharmaceuticals VALIANT Top Line Phase III Results Conference Call Presentation 376.4 KB